Elena B. Khramova

Elena B. Khramova

Auto-generated profile, based on publicly available information

Elena B. Khramova

Tyumen State Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2021 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
VPValentina Peterkova
Valentina Peterkova
OBOlga Bezlepkina
Olga Bezlepkina
NBN. V. Bolotova
N. V. Bolotova
EBE. A. Bogova
E. A. Bogova
OVO. V. Vasyukova
O. V. Vasyukova
EKE. B. Khramova
E. B. Khramova
Childhood obesity is an urgent problem of pediatric endocrinology due to the widespread occurrence, the development of metabolic complications and their steady tracking into adulthood. The developed clinical guidelines are the main working tool of the practitioner. They briefly and structurally present the main information about the epidemiology and modern classification of obesity, methods of its diagnosis and treatment based on the principles of evidence-based medicine.

22 June 2020 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
VPValentina Peterkova
Valentina Peterkova
MSMarina Shestakova
Marina Shestakova
OBOlga Bezlepkina
Olga Bezlepkina
DLDmitry Nikitich Laptev
Dmitry Nikitich Laptev
ТКТамара Леонидовна Кураева
Тамара Леонидовна Кураева
АЕАндрей Олегович Емельянов
Андрей Олегович Емельянов
Сахарный диабет 1 типа у детей

7 December 2020 in Problems of Endocrinology
Verified
Journal Article
Closed access
PDF file
DLDmitry Nikitich Laptev
Dmitry Nikitich Laptev
AEAndrey O. Emelyanov
Andrey O. Emelyanov
YSYulia Samoilova
Yulia Samoilova
EKElena B. Khramova
Elena B. Khramova
EPElena E. Petriaikina
Elena E. Petriaikina
ЮСЮлия Геннадьевна Самойлова
Юлия Геннадьевна Самойлова
RATIONALE: Continuous subcutaneous insulin infusion (CSII) is an effective method for optimizing glycemic control in children with type 1 diabetes mellitus (DM1). However, the use of CSII does not always result in adequate glycemic control. Telehealth can be applied as one of the methods to improve the effectiveness of treatment.AIMS: To evaluate the use of remote medical support of children and adolescents with DM1 and its influence on glycemic control, quality of life, and incidence of acute complications of DM1.MATERIALS AND METHODS: We conducted a 24-week multi-institutional prospective open-label controlled clinical trial. 180 children and adolescents were included in this study and divided into the following categories: 1) age 8–18 years; 2) DM1 at least 1 year; 3) pump insulin therapy Medtronic Paradigm (Medtronic MiniMed, USA) at least 6 months; 4) self-monitoring of glycemia at least 4 times a day and replacement of the insulin pump infusion system at least once every 3 days; 5) inadequate glycemic control of DM1: the level of glycated hemoglobin (HbA1c) 7.5% or higher. Patients were assigned to a remote consultation group (RC; n=100) or a traditional control group (TC; n=80). All patients were trained on the basic principles of DM1 and CSII, and we measured initial HbA1c, then after 12 and 24 weeks, also registered and analyzed glycemic indicators and daily doses of insulin, evaluated and corrected the treatment. Patients or their parents in the RC group sent pump data via the Internet to the pump insulin therapy center at least once every 2 weeks at home and received treatment recommendations in response.RESULTS: The total number of patients included in the study in all institutions was 180 children at 8–18 years. Patients in both groups did not differ in age, gender, duration of DM1 and CSII, and HbA1c level. The total amount of remote consultations for all institutions was 949. The decrease in the level of HbA1c by the end of the study against the initial one was statistically significantly greater in the RC group: 1.17% compared to 0.59% in the TC group (p<0.05). The proportion of patients who reached the target level of HbA1c (<7.5%) was significantly higher in the RC group (32%) compared to the TC group (12.5%, p<0.05). During the study, the incidence of DKA and severe hypoglycemia in the RC group was statistically significantly lower.CONCLUSIONS: Remote monitoring in children with DM1 resulted in significant improvements in glycemic control (HbA1c, glycemic variability, and hypoglycemic frequency). The accumulation of evidence on the effectiveness and safety of telehealth in DM should contribute to implementing this approach in practical health care.

25 November 2021 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
PDF file
VPValentina Peterkova
Valentina Peterkova
OBOlga Bezlepkina
Olga Bezlepkina
ENE. V. Nagaeva
E. V. Nagaeva
TST. Y. Shiryaeva
T. Y. Shiryaeva
OCO. A. Chikulaeva
O. A. Chikulaeva
NBN. V. Bolotova
N. V. Bolotova
The thyroiditis in children are urgent problem of pediatric endocrinology due to the widespread occurrence and characterized by clinical and pathogenetic heterogeneity. The developed clinical guidelines are the main working tool of the practitioner. They briefly and structurally present the main information about the epidemiology and modern classification of thyroiditis, methods of their diagnosis and treatment based on the principles of evidence-based medicine.

4 August 2020 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
VPValentina Peterkova
Valentina Peterkova
AEAndrey O. Emelyanov
Andrey O. Emelyanov
DLDmitry Nikitich Laptev
Dmitry Nikitich Laptev
YSYulia G. Samoylova
Yulia G. Samoylova
EKElena B. Khramova
Elena B. Khramova
СГСамойлова Юлия Геннадьевна
Самойлова Юлия Геннадьевна
BACKGROUND: According to research, only 38% of patients reach glycated hemoglobin targets. It is possible to improve the effectiveness of medical care for children with T1D using modern technologies, including continuous glucose monitoring (CGM). AIMS: To evaluate the effectiveness of outpatient monitoring of children and adolescents with T1D with regular use of professional continuous glucose monitoring. METHODS: The inclusion criteria: age 812 years; T1D at least 1 year; insulin therapy by multiple injections of insulin; inadequate glycemic control of T1D: НbА1с level of 7.5% and higher and / or children and adolescents with frequent episodes of hypoglycemia (usually 4 times a week) or with a history of severe hypoglycemia; signed informed consent. All patients initially and 12 weeks after inclusion in the study conducted a study of the level of НbА1с, and also performed CGM for 6 days. Based on the results of CGM, glycemia indicators and daily doses of insulin were recorded, treatment was evaluated and corrected, and recommendations for self-monitoring were made. Glucose monitoring was carried 120144 hours using the blind method iPro2 (Medtronic, USA). RESULTS: In all, 99 children aged 818 years were included in the study in all centers. The decrease in the level of НbА1с by the end of the study was 0.72%, while the proportion of patients who reached the target level of НbА1с (defined as 7.5%) was statistically significantly higher at the end of the study (15.5% and 2%, respectively; p0.05). During the study, patients showed a trend towards a decrease in the average level and variability of glycemia by the end of the study, however, statistical significance was achieved only in relation to the average level of glycemia (p=0.04). Conducted insulin therapy, determined by the average daily doses of long-acting and short-acting insulin, did not statistically significantly change at the end of the study. The frequency of DKA episodes and severe hypoglycemia did not statistically significantly differ from the initial level. CONCLUSIONS: For children with poor glycemic control of T1D, the use of professional CGM is effective in terms of glycemic control and a safe method.

30 June 2025 in Russian Open Medical Journal
Verified
Journal Article
Closed access
Denis GubinDenis Gubin
Denis Gubin
AMAlexander A. Markov
Alexander A. Markov
SSSvetlana V. Solovieva
Svetlana V. Solovieva
EKElena B. Khramova
Elena B. Khramova
OMOlga A. Malyugina
Olga A. Malyugina
JBJulia V. Boldyreva
Julia V. Boldyreva
An analysis of large-scale studies utilizing actigraphy and wearable devices for continuous monitoring of physiological measures was conducted. Data had been obtained from the UK Biobank and the National Health and Nutrition Examination Survey (NHANES) for use in the studies. The link between circadian rhythm deviations and health status was investigated. The amplitude and phase of circadian rhythms, along with variability parameters of physical activity, skin temperature, and light exposure, were found to be informative markers of key health indicators, including morbidity, mortality, and life expectancy. These findings highlight the critical role of circadian markers – amplitude, phase, and variability – in predicting health risks related to metabolic and sleep disorders, emotional well-being, and cognitive function. By exploring nonlinear associations between chronotype and health risks, we propose that personalized adjustment of sleep-wake phase, based on light hygiene and physical activity regimes and taking into account age, sex, and genetic cofactors, may contribute to the advancement of health-preserving technologies and the extension of human lifespan.